SS

Sagarika Senapati

Active Director Designated Partner DIN 09480039
DIN 09480039 First appointment Jan 2022 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sagarika Senapati

Data last updated:

Sagarika Senapati is a Designated Partner at Alfasa Biotech Llp (since 2022). The company operates in Biotechnology.

DIN 09480039
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 25 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Jan 20222022Active

Board colleagues of Sagarika Senapati

NameDINCompanyDesignation
Subash Chandra Senapati09480040Alfasa Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Alfasa Biotech Llp
Premium access

Shareholding and investment profile for Sagarika Senapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagarika Senapati

Sagarika Senapati currently holds 1 directorship: Alfasa Biotech Llp (Designated Partner, since 25 Jan 2022).

Sagarika Senapati was first appointed on 25 Jan 2022 as Designated Partner at Alfasa Biotech Llp.

The current boards of Sagarika Senapati's companies include Subash Chandra Senapati (Alfasa Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available